Effects of interferon-based therapies in functional cure and hepatocellular carcinoma risk reduction in patients with chronic hepatitis B: real-world evidence from 2-year data of OASIS project

被引：0

作者：

Zhang, Qiran ^{[1
]}

Sun, Feng ^{[1
]}

Yu, Yiqi ^{[1
]}

Zhao, Tingting ^{[1
]}

Sui, Shulan ^{[1
]}

Zhang, Jiming ^{[1
]}

Shang, Jia ^{[2
]}

Geng, Jiawei ^{[3
]}

He, Yignli ^{[4
]}

Guo, Ying ^{[5
]}

Zhao, Caiyan ^{[6
]}

Zhu, Yueyong ^{[7
]}

Yan, Xuebing ^{[8
]}

Zhang, Wenhong ^{[1
]}

机构：

[1] Fudan Univ, Huashan Hosp, Dept Infect Dis, Natl Med Ctr Infect Dis, Shanghai, Peoples R China

[2] Henan Prov Peoples Hosp, Dept Infect Dis, Zhengzhou, Peoples R China

[3] First Peoples Hosp Yunnan Prov, Dept Infect Dis, Kunming, Yunnan, Peoples R China

[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian, Peoples R China

[5] Third Peoples Hosp Taiyuan, Dept Infect Dis, Taiyuan, Peoples R China

[6] Hebei Med Univ, Dept Infect Dis, Affiliated Hosp 3, Shijiazhuang, Hebei, Peoples R China

[7] Fujian Med Univ, Dept Infect Dis, Affiliated Hosp 1, Fuzhou, Peoples R China

[8] Xuzhou Med Univ, Dept Infect Dis, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-147

引用

页码：S1133 / S1134

页数：2

共 24 条

[1] Effects of pegylated interferon-α based therapies on functional cure and the risk of hepatocellular carcinoma development in patients with chronic hepatitis B
Ren, Hong
Huang, Yan
JOURNAL OF VIRAL HEPATITIS, 2019, 26 : 5 - 31
[2] INTERFERON- BASED THERAPIES ARE BENEFICIAL IN CIRRHOTIC HEPATITIS B PATIENTS WITH GOOD LIVER FUNCTION RESERVE: REAL- WORLD EVIDENCE FROM OASIS PROJECT 2.5-YEAR DATA
Zhang, Qiran
Sun, Feng
Yu, Yiqi
Sui, Shulan
Zhao, Tingting
Guo, Ying
Ren, Wanhua
Zhang, Jiming
Huang, Yuxian
Zhang, Wenhong
HEPATOLOGY, 2023, 78 : S527 - S528
[3] Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis
Ji, Fanpu
Zhang, Shu
Deng, Hong
Li, Zongfang
JOURNAL OF HEPATOLOGY, 2013, 58 (06) : 1262 - 1264
[4] Optimize nucleot(s)ide analogues' to prevent hepatocellular carcinoma in patients with chronic hepatitis B: a lesson from real-world evidence
Lim, Jihye
Choi, Jonggi
HEPATOMA RESEARCH, 2021, 7
[5] FUNCTIONAL CURE BASED ON PEGYLATED INTERFERON α-2b THERAPY IN NUCLEOSIDE ANALOG-SUPPRESSED HBEAG NEGATIVE CHRONIC HEPATITIS B: A MULTICENTER REAL-WORLD STUDY (EVEREST PROJECT IN CHINA)-4 YEARS DATA UPDATE
Mo, Zhishuo
Xie, Dongying
Fu, Lei
Zhang, Wenhua
Wei, Jia
Li, Guojun
Yang, Jiahong
Chen, Xinyue
Li, Jiabin
Shang, Jia
Guan, Yujuan
Jiang, Yongfang
Guo, Ying
Zeng, Yilan
Chang, Jiabao
Peng, Yanzhong
Lin, Minghua
Huang, Guangyu
Li, Jia
Gu, Shengwang
Geng, Jiawei
Gao, Zhiliang
HEPATOLOGY, 2022, 76 : S24 - S25
[6] Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk
Ren, Peipei
Cao, Zhujun
Mo, Ruidong
Liu, Yuhan
Chen, Lichang
Li, Ziqiang
Zhou, Tianhui
Lu, Jie
Liu, Yunye
Guo, Qing
Chen, Rong
Zhou, Huijuan
Xiang, Xiaogang
Cai, Wei
Wang, Hui
Bao, Shisan
Xu, Yumin
Gui, Honglian
Xie, Qing
EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1085 - 1094
[7] Interferon-Based Treatment Is Superior to Nucleos(t)Ide Analogue in Reducing HBV-Related Hepatocellular Carcinoma for Chronic Hepatitis B Patients at High Risk
Ren, Peibei
Cao, Zhujun
Mo, Ruidong
Liu, Yuhan
Chen, Lichang
Zhou, Tianhui
Li, Zigiang
Lu, Jie
Liu, Yunye
Guo, Qing
Chen, Rong
Zhou, Huijuan
Cai, Wei
Hui, Wang
Bao, Shisan
Xu, Yumin
Gui, Honglian
Xie, Qing
HEPATOLOGY, 2018, 68 : 1235A - 1235A
[8] Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data update
Xie, Chan
Xie, Dongying
Fu, Lei
Zhang, Wen-hua
Wei, Jia
Li, Guojun
Yang, Jiahong
Chen, Xinyue
Li, Jia-bin
Shang, Jia
Guan, Yu-juan
Jiang, Yongfang
Guo, Ying
Zeng, Yi-lan
Chang, Jiabao
Peng, Yanzhong
Lin, Minghua
Huang, Guangyu
Li, Jia
Gu, Shengwang
Geng, Jia-wei
Gao, Zhiliang
JOURNAL OF HEPATOLOGY, 2022, 77 : S838 - S838
[9] Machine learning-based predictive and risk analysis using real-world data with blood biomarkers for hepatitis B patients in the malignant progression of hepatocellular carcinoma
Nan, Yuemin
Zhao, Suxian
Zhang, Xiaoxiao
Xiao, Zhifeng
Guo, Ruihan
FRONTIERS IN IMMUNOLOGY, 2022, 13
[10] HIGHER HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN CHRONIC HEPATITIS C (CHC) PATIENTS AFTER HEPATITIS C VIRUS (HCV) CURE COMPARED TO TREATED CHRONIC HEPATITIS B (CHB): RESULTS FROM A MULTINATIONAL REAL-WORLD COHORT OF PATIENTS WITH CIRRHOSIS
Park, Jiyoon
Tran, Sally
Ogawa, Eiichi
Huang, Chung-Feng
Toyoda, Hidenori
Chen, Chien Hung
Yeh, Ming-Lun
Tseng, Cheng-Hao
Hsu, Yao-Chun
Kawashima, Keigo
Preda, Carmen
Istratescu, Doina
Yasuda, Satoshi
Nozaki, Akito
Chuma, Makoto
Oh, Hyunwoo
Shim, Jae-Jun
Jeong, Soung Won
An, Jihyun
Ahn, Sang Bong
Kim, Sung Eun
Yoon, Eileen
Lee, Han Ah
Kim, Hyoung Su
Cho, Yong Kyun
Uojima, Haruki
Trinh, Huy
Atsukawa, Masanori
Itokawa, Norio
Okubo, Tomomi
Abe, Hiroshi
Lee, Dong Hyun
Jun, Mi Jung
Landis, Charles
Liu, Joanne
Enomoto, Masaru
Watanabe, Tsunamasa
Ji, Fanpu
Wang, Wenjun
Yu, Li
Xie, Qing
Fukunishi, Shinya
Asai, Akira
Yokohama, Keisuke
Ishikawa, Toru
Liu, Li
Li, Junyi
Takahashi, Hirokazu
Inoue, Kaori
Eguchi, Yuichiro
HEPATOLOGY, 2022, 76 : S377 - S379

← 1 2 3 →